Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-05-24Clinical Trial Update: Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf
This is an epidemiological study update describing management patterns for non-small cell lung cancer in the Middle East and North Africa, s…
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) [Phase 1, Phase 2]
This document summarizes a Phase 1/2 clinical trial evaluating D-CIK cells combined with chemotherapy for non-small cell lung cancer, with t…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash [Phase 2]
Phase 2 trial evaluating metronidazole cream to prevent or treat erlotinib-associated rash in patients with non-squamous non-small cell lung…
-
CLINICAL_TRIALS research · 2016-05-23Clinical Trial Update: Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer [Phase 2, Phase 3]
This clinical trial update describes a study of apatinib in combination with docetaxel as second-line therapy for advanced non-squamous non-…
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Molecular Imaging With Erlotinib and Bevacizumab [Phase 2]
Phase 2 clinical trial update evaluating molecular imaging with erlotinib and bevacizumab in non-small cell lung cancer. The study status is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-05-20Clinical Trial Update: Conmana Combined With Thalidomide to Treat NSCLC [Phase 4]
A Phase 4 clinical trial is evaluating Conmana in combination with thalidomide for non-small cell lung cancer, with the current status liste…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating first-line erlotinib (Tarceva) in combination with gemcitabine for unresectable advanced/metastatic non-small cell …
-
CLINICAL_TRIALS withdrawal · 2016-05-17Clinical Trial Update: Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial of rociletinib in non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 study evaluating KOS-1584 in advanced or metastatic non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating first-line docetaxel plus cisplatin for metastatic non-small cell lung cancer has been suspended.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer [Phase 4]
Phase 4 clinical trial evaluating erlotinib in patients with advanced non-small cell lung cancer has been suspended.
-
CLINICAL_TRIALS withdrawal · 2016-05-12Clinical Trial Update: Electromagnetic Navigational Bronchoscopy Vs. Transthoracic Needle Biopsy for the Sampling of Peripheral Lung Nodules [Phase 2]
A Phase 2 clinical trial comparing Electromagnetic Navigational Bronchoscopy versus Transthoracic Needle Biopsy for sampling peripheral lung…
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: A Phase 1 Study in Participants With Advanced Cancer [Phase 1]
A Phase 1 trial sponsored by Eli Lilly in participants with advanced cancer, including anal squamous cell carcinoma, head and neck squamous …
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients [Phase 2]
Phase 2 clinical trial update reporting on the efficacy and safety of dendritic cytotoxic lymphocyte (DC-CTL) cell infusion in patients with…
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase I study evaluating the combination of Sutent (sunitinib) and Rapamune (sirolimus) in advanced Non-Small Cell Lung Cancer has completed…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating selenium for preventing tumor growth in patients with previously resected stage I non-small cell lung cancer has co…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of quisinostat in combination with chemotherapy in patients with non…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC [Phase 1]
A Phase 1 trial evaluating gated intensity-modulated radiation therapy with concurrent chemotherapy for inoperable non-small cell lung cance…
-
FDA approval · 2016-04-29FDA Approved: XALKORI — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XALKORI (crizotinib) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial comparing pemetrexed plus gefitinib versus gefitinib alone in non-small cell lung cancer completed with results posted.
-
CLINICAL_TRIALS research · 2016-04-28Clinical Trial Update: The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase
This clinical-trial update reports on the evaluation of a lung cancer patient treated with an EGFR tyrosine kinase inhibitor, with the curre…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer [Phase 2]
This ClinicalTrials.gov update reports the termination of a Phase 2 study evaluating pemetrexed with radiation for poor-risk Stage III non-s…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. [Phase 4]
Phase 4 trial assessing Avastin (bevacizumab) with platinum-based chemotherapy in advanced or recurrent non-squamous non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Combination of Chemotherapy and Gefitinib as First-line Treatment [NA]
The document notes the completion of a clinical trial evaluating the combination of chemotherapy and gefitinib as first-line treatment for n…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Phase II Avastin Trial for Stage IIIB/IV NSCLC [Phase 2]
A Phase II trial of Avastin (bevacizumab) for stage IIIB/IV non-small cell lung cancer was terminated.